Navigation Links
Forensic Laboratories Selected for Colorado Companies to Watch Award
Date:4/28/2010

DENVER, April 28 /PRNewswire/ -- Forensic Laboratories, a Denver-based laboratory specializing in toxicology services for drug abuse, has been named one of 50 Colorado Companies to Watch for 2010.  Colorado Companies to Watch is hosted by the Colorado Office of Economic Development and International Trade in partnership with the Edward Lowe Foundation.

The award recognizes second-stage companies that are developing valuable products and services, creating jobs, enriching communities, and creating new industries throughout the state. The winners are recognized for fueling Colorado's economy, accounting for much of the economic growth throughout the state.  Winning companies must be privately held with six to 99 full-time equivalent employees and have $750,000 to $50 million in sales or working capital.

"We are very honored and excited to be recognized as a Colorado Company to Watch," said Michael Gates, vice president for Forensic Laboratories.  "It is a tribute to our entire team who truly understands our core values and who are committed to being part of a successful, growing Colorado-based company."

Earlier this year, Forensic Laboratories unveiled the first oral fluid test for Tapentadol, a new federally approved drug prescribed by pain management doctors.  Tapentadol, approved by the FDA in late 2008, is a narcotic pain reliever used to treat moderate to severe pain.

"Accurate testing is critical for doctors to ensure that patients are compliant in their utilization of the drug," Gates said.  "Oral testing capabilities provide easier, non-invasive collection that potentially eliminates adulterated or substituted samples."

Forensic Laboratories is a centralized laboratory based in Denver with more than 20 years of toxicology experience.  Certified by the Department of Health and Human Services Clinical Laboratory Improvement Amendment (CLIA), Forensic Laboratories utilizes the highest standards of testing and reporting methodologies available to the industry.  Founded in 1986, the company continues to expand testing services for drugs of abuse in human urine, saliva, hair and blood.  The company is an industry leader in Web-based remote data entry and Web-based reporting tools designed to increase the efficacy of drug testing.  Forensic Laboratories seeks test result accuracy derived through a state-of-the-art Laboratory Information System (LIS) for processing, reporting and providing statistical agency and result data.  For more information, visit www.forensiclaboratories.com or call 800-282-6574.


'/>"/>
SOURCE Forensic Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoits Brain
2. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
3. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
4. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
5. Romark Laboratories Raises $18 Million in Institutional Financing
6. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
7. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
8. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
9. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
10. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
11. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
(Date:9/13/2017)... , Sept. 13, 2017   OrthoAtlanta has been ... Atlanta Football Host Committee (AFHC) for the 2018 College Football ... 8, 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... the AFHC "I,m In" campaign, participating in many activities leading ... ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):